Handling of Foreign Particles in APIs and Excipients
Frankfurt am Main, Germany
Course No 18869
Our Service
Costs
| ECA-Member: | EUR 1590,-- |
| Non ECA Member: | EUR 1790,-- |
| EU/GMP Inspectorates: | EUR 895,-- |
| APIC Member Discount: | EUR 1690,-- |
(All prices excl. VAT)
If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org
Speakers
Rajnish Chhabra, QAR Solutions, The Netherlands
Martin Melzer, gempex, Germany
Peter Mungenast, Merck KGaA, Germany
Dirk Overrödder, Cilag, Switzerland
Martin Melzer, gempex, Germany
Peter Mungenast, Merck KGaA, Germany
Dirk Overrödder, Cilag, Switzerland
Objectives
During this course all relevant aspects regarding the control of particles in APIs and excipients will be discussed.
You will learn
You will learn
- How potential sources of insoluble matter can be identified
- Which acceptance criteria for particles can be applied
- How good practices to minimise the presence of particles in APIs can look like
- What has to be considered regarding control of particles during plant and equipment maintenance and cleaning
- How a particulate contamination profile can be established.
Background
Visible particles, insoluble particles or matter or foreign particles in Active Pharmaceutical Ingredients (APIs) and pharmaceutical excipients are topics of great interest and of importance to the pharmaceutical industry.
A number of inspectional observations from various Regulatory Authorities related to visible particles in Drug Products and APIs has risen considerable concern. Moreover inappropriate methods of investigation, controls and preventive and corrective actions were all subjects of citations by authorities and observations by API and excipient customers.
Particles have always been present in APIs and excipients but guidance from health authorities (EMA, FDA, others) or Pharmacopoeias (e.g. EP, USP) about particles is very limited. The APIC Guidance on Insoluble Matter and Foreign Particles in APIs and the IPEC Guide on “Technically Unavoidable Particle Profile (TUPP)" are the only best practice documents so far providing guidance for a standard approach towards an appropriate control of foreign particles in APIs and pharmaceutical excipients.
A number of inspectional observations from various Regulatory Authorities related to visible particles in Drug Products and APIs has risen considerable concern. Moreover inappropriate methods of investigation, controls and preventive and corrective actions were all subjects of citations by authorities and observations by API and excipient customers.
Particles have always been present in APIs and excipients but guidance from health authorities (EMA, FDA, others) or Pharmacopoeias (e.g. EP, USP) about particles is very limited. The APIC Guidance on Insoluble Matter and Foreign Particles in APIs and the IPEC Guide on “Technically Unavoidable Particle Profile (TUPP)" are the only best practice documents so far providing guidance for a standard approach towards an appropriate control of foreign particles in APIs and pharmaceutical excipients.
Target Group
This course is addressed to employees and senior staff of pharmaceutical companies and manufacturers of APIs and excipients. The course is of particular interest to all those working in Quality Assurance, Quality Control, production and purchasing departments.
Programme
Particles and Insoluble Matter in API Manufacturing: Why is it a Topic of Great Interest?
- Definition of particles
- Types of particles
- Possible reasons for the elevated presence of visible particles
- Hints in guidances on how to deal with visible particles
- Inspectional observations
- Expectations of API manufacturers, API users, API suppliers and supervisory authorities regarding visible particles in APIs
Foreign Matter in Pharmaceutical Excipients – How to Deal with “Technically Unavoidable Particles” (TUPs)
- Understanding the nature of contaminants
- Establishing the target profile to support risk assessment
- Establishing the risk profile of unavoidable foreign particles
- Understanding the source and mitigation to minimise the foreign particles
Incident Management – How to Identify the Source of Insoluble Matter
- Potential sources of insoluble matter
- Root cause analysis – examples of investigation techniques and aids
- Risk assessment: topics to be considered during the investigation/disposition decision
Acceptance Criteria for Particles in APIs
- Types of dosage forms and routes of administration
- Typical limits for particle size seen via a filter test
- Proposal for limits
Case Studies:
Deviations Caused by Foreign Particles
Deviations Caused by Foreign Particles
How Can Routine Cleaning Procedures Detect or Minimize the Presence of Particles in API Production?
- Guides and Industry Standards regarding cleaning
- Equipment cleaning
- Production environment cleaning
- Equipment design considerations
- Detection/removal methods of particles
- Preventive measures
Analytical Control Methods for Particle Detection
- Design of appropriate analytical techniques
- Understanding the operational and investigative analytical methodologies
- Case studies to identify the contaminants
Foreign Particles in Excipients and Finished Product Quality and Safety
- Contamination Profile of Excipients meets Finished Product Quality Target Product Profile
- Excipient Process Risk Analysis and TUPP/ Particulate Contamination Profiling
GMP Conferences by Topics
- Quality Assurance
- GMP in Biotechnology
- Microbiology
- Regulatory Affairs
- GMP in Pharmaceutical Development
- Quality Control
- GDP
- Sterile / Aseptic Manufacturing
- Computer Validation
- Validation
- Technical Operations
- GMP for APIs and Excipients
- Medical Devices
- GMP Basic Training Courses
- Packaging
- Data Integrity